Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRASTUZUMAB Cause Maternal exposure timing unspecified? 25 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Maternal exposure timing unspecified have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.1% of all adverse event reports for TRASTUZUMAB.

25
Reports of Maternal exposure timing unspecified with TRASTUZUMAB
0.1%
of all TRASTUZUMAB reports
1
Deaths
14
Hospitalizations

How Dangerous Is Maternal exposure timing unspecified From TRASTUZUMAB?

Of the 25 reports, 1 (4.0%) resulted in death, 14 (56.0%) required hospitalization, and 6 (24.0%) were considered life-threatening.

Is Maternal exposure timing unspecified Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 25 reports have been filed with the FAERS database.

What Other Side Effects Does TRASTUZUMAB Cause?

Diarrhoea (4,996) Off label use (3,802) Nausea (3,499) Fatigue (3,417) Myelosuppression (2,552) Disease progression (2,449) Death (2,378) Vomiting (2,244) Dyspnoea (2,010) Pyrexia (1,886)

What Other Drugs Cause Maternal exposure timing unspecified?

RITUXIMAB (402) METHOTREXATE (350) ADALIMUMAB (343) DICLOFENAC (331) TOCILIZUMAB (327) HYDROXYCHLOROQUINE (309) FOLIC ACID (304) INFLIXIMAB (303) LEFLUNOMIDE (302) SECUKINUMAB (301)

Which TRASTUZUMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?

TRASTUZUMAB vs TRASTUZUMAB-ANNS TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN TRASTUZUMAB vs TRASTUZUMAB-DKST TRASTUZUMAB vs TRASTUZUMAB-DTTB TRASTUZUMAB vs TRASTUZUMAB EMTANSINE

Related Pages

TRASTUZUMAB Full Profile All Maternal exposure timing unspecified Reports All Drugs Causing Maternal exposure timing unspecified TRASTUZUMAB Demographics